It has been reported that CK promoted cholesterol efflux by stimulating LXRα [29, 30], and we recognized the increased expression of LXRα in resistant GBM cells after treated with Rb1, Rg1, and Rg3, in addition to CK. The gene discussed is RB1; the disease is glioblastoma.